The Norwegian plasma fractionation project––a 12 year clinical and economic success story
- 1 February 2003
- journal article
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 28 (1) , 93-100
- https://doi.org/10.1016/s1473-0502(02)00104-0
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Universal solvent/detergent-treated fresh frozen plasma (Uniplas®)—rationale and clinical propertiesThrombosis Research, 2002
- Effects of solvent/detergent‐treated plasma and fresh‐frozen plasma on haemostasis and fibrinolysis in complex coagulopathy following open‐heart surgeryVox Sanguinis, 2002
- Complement Activation in Patients With Congestive Heart FailureCirculation, 2001
- Immunomodulating Therapy With Intravenous Immunoglobulin in Patients With Chronic Heart FailureCirculation, 2001
- Viral safety of solvent/detergent‐treated plasmaTransfusion, 2000
- Solvent/Detergent-Treated Plasma Has Decreased Antitrypsin Activity and Absent Antiplasmin ActivityBlood, 1999
- Administration of intravenous immunoglobulin (IVIG)in vivo—down-regulatory effects on the IL-1 systemClinical and Experimental Immunology, 1999
- Viral Safety of Blood Derivatives by Immune NeutralizationVox Sanguinis, 1998
- Manufacture and in vitro Characterization of a Solvent/Detergent‐Treated Human PlasmaVox Sanguinis, 1992
- HIV infection in Norwegian haemophiliacs: The prevalence of antibodies against HIV in haemophiliacs treated with lyophilized cryoprecipitate from volunteer donorsEuropean Journal of Haematology, 1987